Federico II University
Naples, 80131, Italy
NCT Number: NCT03899974
The amylose-amylopectin ratio influences starch properties. A higher amylose content is associated with slower starch digestion thus reducing the postprandial plasma glucose response and improving the overall postprandial metabolism. So far, limited evidence is available on the metabolic effect of wheat-based foods rich in amylose. This randomised controlled study investigated the acute metabolic effects of amylose-rich wheat-based breads in overweight subjects focusing on potential mechanisms.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Naples, 80131, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants received in random order the three test meal (700Kcal, 80g available carbohydrates) containing breads prepared with amylose-rich wheat flours (70% or 85%) or conventional flour. Blood samples were collected at fasting and every 30 minutes over 4 hours. Breath hydrogen was evaluated as a marker of intestinal fermentation. Participants underwent Visual Analogue Scale to assess subjective appetite sensations.
After 4 hours, all participants consumed a standard lunch (700 kcal, 100 g available carbohydrates) identical on all the three experimental days to evaluate the "second meal effect" from breakfast to lunch.
Time frame: over 2 hours after the test meal
incremental area under the curve
Time frame: over 2 hours after the test meal
incremental area under the curve
Time frame: over 4 hours after the test meal
incremental area under the curve
Time frame: over 4 hours after the test meal
incremental area under the curve
Time frame: over 4 hours after the test meal
breath test for the detection of hydrogen production
Time frame: over 2 hours after the standard meal
Second meal effect
Federico II University
Other
Metabolic Effects of High-amylose Wheat-based Breads in Overweight Individuals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03836495
Energy Expenditure, Glucose Metabolism Disorders
Beirut, Lebanon
View Trial DetailsNCT04430439
Behavior, Behavioral Symptoms
Irvine, California, United States
View Trial DetailsNCT05783752
Glucose Metabolism Disorders, Hyperglycemia
San Diego, California, United States
View Trial DetailsNCT03624569
Bacteremia, Cardiovascular Diseases
Columbus, Ohio, United States
View Trial Details